Published in Circulation on January 30, 2001
A mutant, noninhibitory plasminogen activator inhibitor type 1 decreases matrix accumulation in experimental glomerulonephritis. J Clin Invest (2003) 1.42
Etk/Bmx as a tumor necrosis factor receptor type 2-specific kinase: role in endothelial cell migration and angiogenesis. Mol Cell Biol (2002) 1.37
Fluid flow mechanotransduction in vascular smooth muscle cells and fibroblasts. Ann Biomed Eng (2011) 1.32
Fluid Mechanics, Arterial Disease, and Gene Expression. Annu Rev Fluid Mech (2014) 1.00
PAI-1 and kidney fibrosis. Front Biosci (Landmark Ed) (2009) 0.97
Ethanol stimulates endothelial cell angiogenic activity via a Notch- and angiopoietin-1-dependent pathway. Cardiovasc Res (2008) 0.97
Biomechanical regulation of vascular smooth muscle cell functions: from in vitro to in vivo understanding. J R Soc Interface (2013) 0.97
Renal fibrosis: not just PAI-1 in the sky. J Clin Invest (2003) 0.96
MicroRNA 329 suppresses angiogenesis by targeting CD146. Mol Cell Biol (2013) 0.93
Antimetastatic potential of PAI-1-specific RNA aptamers. Oligonucleotides (2009) 0.93
Ang II-stimulated migration of vascular smooth muscle cells is dependent on LR11 in mice. J Clin Invest (2008) 0.89
Endothelial injury induces vascular smooth muscle cell proliferation in highly localized regions of a direct contact co-culture system. Cell Biochem Biophys (2008) 0.86
Comparison of artery organ culture and co-culture models for studying endothelial cell migration and its effect on smooth muscle cell proliferation and migration. Ann Biomed Eng (2009) 0.82
Acetaldehyde stimulates monocyte adhesion in a P-selectin- and TNFalpha-dependent manner. Atherosclerosis (2008) 0.80
Modulation of glomerulosclerosis. Semin Immunopathol (2007) 0.79
Randomized Comparison of the Crush Versus the Culotte Stenting for Coronary Artery Bifurcation Lesions. Chin Med J (Engl) (2016) 0.78
Nicotine facilitates VSMC dysfunction through a miR-200b/RhoGDIA/cytoskeleton module. Sci Rep (2017) 0.75
Endothelial function and germ-line ACE I/D, eNOS and PAI-1 gene profiles in patients with coronary slow flow in the Canakkale population: multiple thrombophilic gene profiles in coronary slow flow. Cardiovasc J Afr (2014) 0.75
Vitronectin-binding PAI-1 protects against the development of cardiac fibrosis through interaction with fibroblasts. Lab Invest (2014) 0.75
Safety and antitumor activity of recombinant soluble Apo2 ligand. J Clin Invest (1999) 7.69
Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients. Ann Surg (1995) 5.66
Improved hospital morbidity, mortality, and survival after the Whipple procedure. Ann Surg (1987) 5.58
Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer. Am J Surg (1991) 3.88
WISP genes are members of the connective tissue growth factor family that are up-regulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors. Proc Natl Acad Sci U S A (1998) 3.73
Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. Immunity (2000) 3.45
Immunoglobulins cytophilic for human lymphocytes, monocytes, and neutrophils. J Clin Invest (1975) 3.39
The serpin PAI-1 inhibits cell migration by blocking integrin alpha V beta 3 binding to vitronectin. Nature (1996) 3.34
Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer. Nature (1998) 2.98
Normal embryo fibroblasts release transforming growth factors in a latent form. J Cell Physiol (1984) 2.76
Conversion of a high molecular weight latent beta-TGF from chicken embryo fibroblasts into a low molecular weight active beta-TGF under acidic conditions. Biochem Biophys Res Commun (1985) 2.75
Regulation of methionine synthesis in Salmonella typhimurium: mutants resistant to inhibition by analogues of methionine. Genetics (1968) 2.62
Death receptor recruitment of endogenous caspase-10 and apoptosis initiation in the absence of caspase-8. J Biol Chem (2001) 2.40
Purification of an inhibitor of plasminogen activator (antiactivator) synthesized by endothelial cells. J Biol Chem (1984) 2.22
Regional chemotherapy devices: effect of experience and anatomy on complications. J Clin Oncol (1993) 2.09
Strand-selective repair of DNA damage in the yeast GAL7 gene requires RNA polymerase II. J Biol Chem (1992) 1.94
Neuroserpin reduces cerebral infarct volume and protects neurons from ischemia-induced apoptosis. Blood (2000) 1.90
Beta-transforming growth factor is stored in human blood platelets as a latent high molecular weight complex. Biochem Biophys Res Commun (1986) 1.90
Familial dementia caused by polymerization of mutant neuroserpin. Nature (1999) 1.88
Further study of beta-TGFs released by virally transformed and non-transformed cells. Int J Cancer (1985) 1.77
Molecular evolution of plasminogen activator inhibitor-1 functional stability. EMBO J (1995) 1.73
Current management of the Budd-Chiari syndrome. Ann Surg (1990) 1.68
Should hepatic resections be performed at high-volume referral centers? J Gastrointest Surg (1999) 1.65
Reverse fibrin autography: a method to detect and partially characterize protease inhibitors after sodium dodecyl sulfate--polyacrylamide gel electrophoresis. Anal Biochem (1984) 1.59
Preferential repair of DNA damage on the transcribed strand of the human metallothionein genes requires RNA polymerase II. Mutat Res (1991) 1.58
Plasminogen activator inhibitor-1 regulates tumor growth and angiogenesis. J Biol Chem (2001) 1.58
Increased MAPK expression and activity in primary human hepatocellular carcinoma. Biochem Biophys Res Commun (1997) 1.53
Latent beta-transforming growth factor in nontransformed and Kirsten sarcoma virus-transformed normal rat kidney cells, clone 49F. Cancer Res (1984) 1.51
Intensive chemoradiation followed by esophagectomy for squamous cell and adenocarcinoma of the esophagus. Cancer J Sci Am (1997) 1.51
Risk factors for central venous catheter-related vascular erosions. JPEN J Parenter Enteral Nutr (1991) 1.51
The thrombomodulin analog Solulin promotes reperfusion and reduces infarct volume in a thrombotic stroke model. J Thromb Haemost (2011) 1.51
Dietary fish oil and olive oil supplementation in patients with rheumatoid arthritis. Clinical and immunologic effects. Arthritis Rheum (1990) 1.50
Neuroserpin, a brain-associated inhibitor of tissue plasminogen activator is localized primarily in neurons. Implications for the regulation of motor learning and neuronal survival. J Biol Chem (1997) 1.47
Every-other-week methotrexate in patients with rheumatoid arthritis. A double-blind, placebo-controlled prospective study. Arthritis Rheum (1995) 1.44
Biliary tract anomalies associated with intestinal malrotation in the adult. Surgery (1993) 1.43
Plasminogen activator inhibitor-1 contains a cryptic high affinity binding site for the low density lipoprotein receptor-related protein. J Biol Chem (1998) 1.42
Identification of glycoprotein 330 as an endocytic receptor for apolipoprotein J/clusterin. J Biol Chem (1995) 1.41
Regulation of atrial natriuretic factor receptors in portal hypertensive rabbits. J Hepatol (1996) 1.40
The active conformation of plasminogen activator inhibitor 1, a target for drugs to control fibrinolysis and cell adhesion. Structure (1999) 1.40
Inhibition of angiogenesis in vivo by plasminogen activator inhibitor-1. J Biol Chem (2000) 1.40
Septic and technical complications of central venous catheterization. A prospective study of 200 consecutive patients. Ann Surg (1985) 1.39
The catecholamine, cortisol, and hemodynamic responses to mild perioperative hypothermia. A randomized clinical trial. Anesthesiology (1995) 1.38
Cytophilic properties of IgA to human neutrophils. Adv Exp Med Biol (1974) 1.38
Cell cycle progression of glutathione-depleted human peripheral blood mononuclear cells is inhibited at S phase. J Immunol (1989) 1.38
The urokinase receptor is expressed in invasive breast cancer but not in normal breast tissue. Cancer Res (1994) 1.36
Identification of the low density lipoprotein receptor-related protein (LRP) as an endocytic receptor for thrombospondin-1. J Cell Biol (1995) 1.30
Activated T cells enhance nitric oxide production by murine splenic macrophages through gp39 and LFA-1. Eur J Immunol (1995) 1.23
Characterization of an IgE receptor isolated from cultured B-type lymphoblastoid cells. J Immunol (1978) 1.23
Effect of pharmacologic plasminogen activator inhibitor-1 inhibition on cell motility and tumor angiogenesis. J Thromb Haemost (2006) 1.21
Laparoscopic donor nephrectomy with a 23-hour stay: a new standard for transplantation surgery. Ann Surg (2000) 1.18
Cubilin, the endocytic receptor for intrinsic factor-vitamin B(12) complex, mediates high-density lipoprotein holoparticle endocytosis. Proc Natl Acad Sci U S A (1999) 1.18
Lead differentially modifies cytokine production in vitro and in vivo. Toxicol Appl Pharmacol (1996) 1.17
A fluorescent probe study of plasminogen activator inhibitor-1. Evidence for reactive center loop insertion and its role in the inhibitory mechanism. J Biol Chem (1995) 1.16
Familial encephalopathy with neuroserpin inclusion bodies. Am J Pathol (1999) 1.16
Regulation of the methionine-specific aspartokinase and homoserine dehydrogenase of Salmonella typhimurium. J Gen Microbiol (1968) 1.13
Management of massive retroperitoneal hemorrhage from an adrenal tumor. Endocr J (2001) 1.11
Altered expression of mitogen-activated protein kinases in a rat model of experimental hepatocellular carcinoma. Hepatology (1997) 1.10
Neuroserpin mutation S52R causes neuroserpin accumulation in neurons and is associated with progressive myoclonus epilepsy. J Neuropathol Exp Neurol (2000) 1.08
2,4-Dinitrophenyl receptors on mouse thymus and spleen cells. J Exp Med (1973) 1.07
Cytokine-responsive gene-2/IFN-inducible protein-10 expression in multiple models of liver and bile duct injury suggests a role in tissue regeneration. J Immunol (2001) 1.07
Corticotropin, cortisol and beta-endorphin responses to the human corticotropin-releasing hormone during melancholia and after unilateral electroconvulsive therapy. Acta Psychiatr Scand (1990) 1.06
Stimulation of murine lymphocyte responses by cations. Cell Immunol (1986) 1.06
Effects of high-dose fish oil on rheumatoid arthritis after stopping nonsteroidal antiinflammatory drugs. Clinical and immune correlates. Arthritis Rheum (1995) 1.06
Acidic cellular environments: activation of latent TGF-beta and sensitization of cellular responses to TGF-beta and EGF. Int J Cancer (1989) 1.05
Functional venous anatomy for right-lobe grafting and techniques to optimize outflow. Liver Transpl (2001) 1.05
Saturation mutagenesis of the plasminogen activator inhibitor-1 reactive center. J Biol Chem (1992) 1.05
Endothelial dysfunction in cirrhosis and portal hypertension. Pharmacol Ther (2001) 1.04
Inactivation of plasminogen activator inhibitor by oxidants. Biochemistry (1986) 1.04
Adrenergic, respiratory, and cardiovascular effects of core cooling in humans. Am J Physiol (1997) 1.04
Identification and activation of latent transforming growth factor beta. Methods Enzymol (1991) 1.04
Susceptibility of C5-deficient mice to listeriosis: modulation by Concanavalin A. Cell Immunol (1978) 1.04
Increased endothelial nitric oxide synthase activity in the hyperemic vessels of portal hypertensive rats. J Hepatol (1996) 1.04
Treatment of male hypogonadism with testosterone enanthate. J Clin Endocrinol Metab (1980) 1.03
Role of the catalytic serine in the interactions of serine proteinases with protein inhibitors of the serpin family. Contribution of a covalent interaction to the binding energy of serpin-proteinase complexes. J Biol Chem (1995) 1.02
Patterns of ileal recurrence in Crohn's disease. A prospective randomized study. Ann Surg (1992) 1.01
Characterization of the binding of different conformational forms of plasminogen activator inhibitor-1 to vitronectin. Implications for the regulation of pericellular proteolysis. J Biol Chem (1997) 1.01
Regulation of the methionine feedback-sensitive enzyme in mutants of Salmonella typhimurium. J Bacteriol (1972) 1.01
Plasminogen activator system in human coronary atherosclerosis. Arterioscler Thromb Vasc Biol (1995) 1.01
Alteration of transforming growth factor-beta1 response involves down-regulation of Smad3 signaling in myofibroblasts from skin fibrosis. Am J Pathol (2001) 0.99
Mesoatrial shunt hemodynamics. Surgery (1988) 0.99
Overexpression of urokinase receptor increases matrix invasion without altering cell migration in a human osteosarcoma cell line. Cancer Res (1993) 0.98
Portal-phase contrast-enhanced helical CT for the detection of malignant hepatic tumors: sensitivity based on comparison with intraoperative and pathologic findings. AJR Am J Roentgenol (1996) 0.98
The serpin-proteinase complex revealed. Nat Struct Biol (1997) 0.96
Level of methionyl-tRNA synthetase in merodiploids of Escherichia coli K12. Eur J Biochem (1970) 0.94
Measurement of macrophage adherence and spreading with weak electric fields. J Immunol Methods (1990) 0.94
In vivo the environmental pollutants lead and mercury induce oligoclonal T cell responses skewed toward type-2 reactivities. Cell Immunol (1997) 0.94
Transforming growth factor-beta1 enhances the lethal effects of DNA-damaging agents in a human lung-cancer cell line. Int J Cancer (1997) 0.94
A histological comparison of adenomatous and hyperplastic parathyroid glands. J Clin Pathol (1978) 0.93
Reversal by antrectomy of endocrine cell hyperplasia in the gastric body in pernicious anemia: a morphometric study. Mod Pathol (1990) 0.93
Serpin conformational change in ovalbumin. Enhanced reactive center loop insertion through hinge region mutations. Biochemistry (1997) 0.93
Ethanol enhances basal and flow-stimulated nitric oxide synthase activity in vitro by activating an inhibitory guanine nucleotide binding protein. J Pharmacol Exp Ther (1999) 0.93
Cells transformed by Rous sarcoma virus release transforming growth factors. J Cell Physiol (1982) 0.93
New Zealand mixed mice: a genetic systemic lupus erythematosus model for assessing environmental effects. Environ Health Perspect (1999) 0.92
Ethanol inhibits mitogen activated protein kinase activity and growth of vascular smooth muscle cells in vitro. Eur J Pharmacol (1998) 0.92